192 related articles for article (PubMed ID: 17002555)
1. RANKL treatment releases the negative regulation of the poly(ADP-ribose) polymerase-1 on Tcirg1 gene expression during osteoclastogenesis.
Beranger GE; Momier D; Rochet N; Quincey D; Guigonis JM; Samson M; Carle GF; Scimeca JC
J Bone Miner Res; 2006 Nov; 21(11):1757-69. PubMed ID: 17002555
[TBL] [Abstract][Full Text] [Related]
2. Differential binding of poly(ADP-Ribose) polymerase-1 and JunD/Fra2 accounts for RANKL-induced Tcirg1 gene expression during osteoclastogenesis.
Beranger GE; Momier D; Guigonis JM; Samson M; Carle GF; Scimeca JC
J Bone Miner Res; 2007 Jul; 22(7):975-83. PubMed ID: 17419679
[TBL] [Abstract][Full Text] [Related]
3. Poly(adp-ribose) polymerase-1 regulates Tracp gene promoter activity during RANKL-induced osteoclastogenesis.
Beranger GE; Momier D; Rochet N; Carle GF; Scimeca JC
J Bone Miner Res; 2008 Apr; 23(4):564-71. PubMed ID: 18021007
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha expression is transcriptionally regulated by RANK ligand.
Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z
J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596
[TBL] [Abstract][Full Text] [Related]
5. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
6. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
7. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
[TBL] [Abstract][Full Text] [Related]
8. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration.
Ishida N; Hayashi K; Hattori A; Yogo K; Kimura T; Takeya T
J Bone Miner Res; 2006 Jan; 21(1):48-57. PubMed ID: 16355273
[TBL] [Abstract][Full Text] [Related]
9. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
Kitazawa R; Kitazawa S
Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase.
Simbulan-Rosenthal CM; Rosenthal DS; Boulares AH; Hickey RJ; Malkas LH; Coll JM; Smulson ME
Biochemistry; 1998 Jun; 37(26):9363-70. PubMed ID: 9649317
[TBL] [Abstract][Full Text] [Related]
13. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
14. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
15. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
20. RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.
Chen J; Sun Y; Mao X; Liu Q; Wu H; Chen Y
J Biol Chem; 2010 Nov; 285(47):36315-21. PubMed ID: 20837480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]